132 related articles for article (PubMed ID: 38761320)
1. Effect of American genomic ancestry on severe toxicities in children with acute lymphoblastic leukemia in the Amazon region.
Wanderley AV; de Moraes FCA; da Costa Nunes GG; Pereira EEB; Leitão LPC; de Oliveira MB; Tavares ÁTM; da Costa Pantoja L; Khayat BCM; Fernandes MR; de Assumpção PP; Dos Santos ÂKR; Burbano RMR; Dos Santos SEB; Ribeiro R; Khayat AS; Dos Santos NPC
Discov Oncol; 2024 May; 15(1):171. PubMed ID: 38761320
[TBL] [Abstract][Full Text] [Related]
2. The Role of
Fernandes SSM; Leitão LPC; Cohen-Paes AN; Gellen LPA; Pastana LF; de Carvalho DC; Modesto AAC; da Costa ACA; Wanderley AV; Lima CHV; Pereira EEB; Fernandes MR; Burbano RMR; de Assumpção PP; Santos SEBD; Santos NPCD
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456416
[TBL] [Abstract][Full Text] [Related]
3. Association between the
Cardoso de Carvalho D; Pereira Colares Leitão L; Mello Junior FAR; Vieira Wanderley A; Souza TP; Borges Andrade de Sá R; Cohen-Paes A; Rodrigues Fernandes M; Santos S; Salim Khayat A; Pimentel de Assumpção P; Pereira Carneiro Dos Santos N
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32992962
[TBL] [Abstract][Full Text] [Related]
4. Amerindian genetic ancestry and INDEL polymorphisms associated with susceptibility of childhood B-cell Leukemia in an admixed population from the Brazilian Amazon.
Carvalho DC; Wanderley AV; Amador MA; Fernandes MR; Cavalcante GC; Pantoja KB; Mello FA; de Assumpção PP; Khayat AS; Ribeiro-Dos-Santos Â; Santos S; Dos Santos NP
Leuk Res; 2015 Aug; ():. PubMed ID: 26321572
[TBL] [Abstract][Full Text] [Related]
5. Characterization of pharmacogenetic markers related to Acute Lymphoblastic Leukemia toxicity in Amazonian native Americans population.
de Carvalho DC; Wanderley AV; Dos Santos AMR; Moreira FC; de Sá RBA; Fernandes MR; Modesto AAC; de Souza TP; Cohen-Paes A; Leitão LPC; Rodrigues JCG; da Silva ALDC; Guerreiro JF; Santos S; Khayat AS; de Assumpção PP; Dos Santos NPC
Sci Rep; 2020 Jun; 10(1):10292. PubMed ID: 32581388
[TBL] [Abstract][Full Text] [Related]
6. Influence of Genetic Variations in miRNA and Genes Encoding Proteins in the miRNA Synthesis Complex on Toxicity of the Treatment of Pediatric B-Cell ALL in the Brazilian Amazon.
da Silva Menezes E; de Moraes FCA; de Nazaré Cohen-Paes A; Wanderley AV; Pereira EEB; Pastana LF; Modesto AAC; de Assumpção PP; Burbano RMR; Dos Santos SEB; Dos Santos NPC; Fernandes MR
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901860
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group.
Junk SV; Schaeffeler E; Zimmermann M; Möricke A; Beier R; Schütte P; Fedders B; Alten J; Hinze L; Klein N; Kulozik A; Muckenthaler MU; Koehler R; Borkhardt A; Vijayakrishnan J; Ellinghaus D; Forster M; Franke A; Wintering A; Kratz CP; Schrappe M; Schwab M; Houlston RS; Cario G; Stanulla M
J Exp Clin Cancer Res; 2023 Jan; 42(1):21. PubMed ID: 36639636
[TBL] [Abstract][Full Text] [Related]
10. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
Sato A; Hatta Y; Imai C; Oshima K; Okamoto Y; Deguchi T; Hashii Y; Fukushima T; Hori T; Kiyokawa N; Kato M; Saito S; Anami K; Sakamoto T; Kosaka Y; Suenobu S; Imamura T; Kada A; Saito AM; Manabe A; Kiyoi H; Matsumura I; Koh K; Watanabe A; Miyazaki Y; Horibe K
Lancet Haematol; 2023 Jun; 10(6):e419-e432. PubMed ID: 37167992
[TBL] [Abstract][Full Text] [Related]
11. Identification of Genomic Variants Associated with the Risk of Acute Lymphoblastic Leukemia in Native Americans from Brazilian Amazonia.
Leitão LPC; de Carvalho DC; Rodrigues JCG; Fernandes MR; Wanderley AV; Vinagre LWMS; da Silva NM; Pastana LF; Gellen LPA; Assunção MCE; Fernandes SSM; Pereira EEB; Ribeiro-Dos-Santos AM; Guerreiro JF; Ribeiro-Dos-Santos Â; de Assumpção PP; Dos Santos SEB; Dos Santos NPC
J Pers Med; 2022 May; 12(6):. PubMed ID: 35743641
[TBL] [Abstract][Full Text] [Related]
12. Genetic ancestry, differential gene expression, and survival in pediatric B-cell acute lymphoblastic leukemia.
Barragan FA; Mills LJ; Raduski AR; Marcotte EL; Grinde KE; Spector LG; Williams LA
Cancer Med; 2023 Feb; 12(4):4761-4772. PubMed ID: 36127808
[TBL] [Abstract][Full Text] [Related]
13. Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia.
Lee SHR; Antillon-Klussmann F; Pei D; Yang W; Roberts KG; Li Z; Devidas M; Yang W; Najera C; Lin HP; Tan AM; Ariffin H; Cheng C; Evans WE; Hunger SP; Jeha S; Mullighan CG; Loh ML; Yeoh AEJ; Pui CH; Yang JJ
JAMA Oncol; 2022 Mar; 8(3):354-363. PubMed ID: 35084434
[TBL] [Abstract][Full Text] [Related]
14. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
15. Amerindian genetic ancestry as a risk factor for tuberculosis in an amazonian population.
Leal DFDVB; Santana da Silva MN; Fernandes DCRO; Rodrigues JCG; Barros MCDC; Pinto PDDC; Pastana LF; Silva CAD; Fernandes MR; Assumpção PP; Santos SEBD; Dos Santos NPC
PLoS One; 2020; 15(7):e0236033. PubMed ID: 32673332
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs.
Burgueño-Rodríguez G; Méndez Y; Olano N; Schelotto M; Castillo L; Soler AM; da Luz J
Front Pharmacol; 2023; 14():1278769. PubMed ID: 38044950
[TBL] [Abstract][Full Text] [Related]
17. Ancestry and TPMT-VNTR Polymorphism: Relationship with Hematological Toxicity in Uruguayan Patients with Acute Lymphoblastic Leukemia.
Burgueño-Rodríguez G; Méndez Y; Olano N; Dabezies A; Bertoni B; Souto J; Castillo L; da Luz J; Soler AM
Front Pharmacol; 2020; 11():594262. PubMed ID: 33424606
[TBL] [Abstract][Full Text] [Related]
18. [Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary].
Müller J; Kovács G; Jakab Z; Rényi I; Galántai I; Békési A; Kiss C; Nagy K; Kajtár P; Bartyik K; Masát P; Magyarosy E
Orv Hetil; 2005 Jan; 146(2):75-80. PubMed ID: 15724956
[TBL] [Abstract][Full Text] [Related]
19. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
[TBL] [Abstract][Full Text] [Related]
20. BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia.
Avgeris M; Stamati L; Kontos CK; Piatopoulou D; Marmarinos A; Xagorari M; Baka M; Doganis D; Anastasiou T; Kosmidis H; Gourgiotis D; Scorilas A
Clin Chem Lab Med; 2018 Nov; 56(12):2104-2118. PubMed ID: 30016275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
